AldAgen.com

About AldAgen.com

Aldagen is a biopharmaceutical company developing proprietary regenerative cell therapies that target significant unmet medical needs. The company's most advanced product candidates are ALD-101, ALD-301 and ALD-201. Aldagen is currently conducting a pivotal Phase 3 clinical trial of ALD-101 for improving umbilical cord blood transplants used to treat inherited metabolic diseases in pediatric patients.

Domain Resolution

This domain resolves to the following IP addresses:


Retrieved from "http://aboutus.com/index.php?title=AldAgen.com&oldid=58101591"